0001806356-21-000001.txt : 20210518
0001806356-21-000001.hdr.sgml : 20210518
20210518125749
ACCESSION NUMBER: 0001806356-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
EFFECTIVENESS DATE: 20210518
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: 858 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001806356
IRS NUMBER: 834651777
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-399747
FILM NUMBER: 21935307
BUSINESS ADDRESS:
STREET 1: 4757 NEXUS CENTER DRIVE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-987-8380
MAIL ADDRESS:
STREET 1: 4757 NEXUS CENTER DRIVE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001806356
858 Therapeutics, Inc.
4757 NEXUS CENTER DRIVE
SUITE 150
SAN DIEGO
CA
CALIFORNIA
92121
858-987-8380
DELAWARE
None
None
Corporation
true
2019
Carlo
Rizzuto
c/o 858 Therapeutics, Inc.
4757 Nexus Center Drive, Suite 150
San Diego
CA
CALIFORNIA
92121
Director
Clare
Ozawa
c/o 858 Therapeutics, Inc.
4757 Nexus Center Drive, Suite 150
San Diego
CA
CALIFORNIA
92121
Director
James
Veal
c/o 858 Therapeutics, Inc.
4757 Nexus Center Drive, Suite 150
San Diego
CA
CALIFORNIA
92121
Executive Officer
Jeffrey
A.
Stafford
c/o 858 Therapeutics, Inc.
4757 Nexus Center Drive, Suite 150
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Ali
Behbahani
c/o 858 Therapeutics, Inc.
4757 Nexus Center Drive, Suite 150
San Diego
CA
CALIFORNIA
92121
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-05-04
false
true
false
0
39999996
20000001
19999995
false
6
0
0
0
false
858 Therapeutics, Inc.
Jeffrey A. Stafford
Jeffrey A. Stafford
President and Chief Executive Officer
2021-05-18